Favorite flu fighters: Tamiflu or Relenza?
I can find no clinical evidence that Tamiflu--one of the two main pharmaceutical weapons against an epidemic or pandemic of Type A influenza--is substantially more effective than its competitor Relenza.I can find abundant evidence, however, that Switzerland's Roche has much better packaging for Tamiflu, and that it is therefore (a lot) more expensive than GlaxoSmithKline's Relenza.